Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

health

  • ‘Day of shame’: Rishi Sunak apologises for infected blood scandal

    May 20, 2024

    Rishi Sunak has made a “wholehearted and unequivocal apology” for the infected blood scandal in what he said was a “day of shame” for  the British state.

  • Astrazeneca to build huge new cancer drug plant in Singapore

    May 20, 2024

    Astrazeneca has said it will invest $1.5bn (£1.2bn) to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment.

  • How business leaders can embrace shift to healthier office dining

    May 20, 2024

    The healthier office landscape is in a constant state of evolution, and the recent embrace of hybrid work models has only accelerated these changes.

  • Ozempic and Wegovy: What happens when a drug goes viral?

    May 18, 2024

    Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?

  • Let’s be honest: ‘miracle drug’ Ozempic will be a game-changer on obesity

    May 16, 2024

    What if there was already a proven way to reduce obesity and improve health without government intervention? There is and it’s called Ozempic, says Matt Lesh A new study out this week claims that rising work absenteeism is being driven by obesity. There are reasons to doubt these findings. Official data from the Office for [...]

  • Polar Capital Healthcare trust rockets to success thanks to strong stock selection

    May 16, 2024

    The trust performed much better than the previous year, where it grew only 4.2 per cent, thanks to strong stock selection and managing to outperform an already booming healthcare market.

  • When the drugs don’t work: How the UK became addicted to antidepressants

    May 14, 2024

    Almost one in four adults are being prescribed antidepressants, but they are not as effective as was once believed, writes Lucy Kenningham

  • Long-term sickness now top reason for women being out of work

    May 13, 2024

    Long-term sickness has become the main reason for women being out of work, according to research by one trade union.

  • Therapie Clinic rolls out trending polynucleotides skin treatment

    May 8, 2024

    Therapie is one of the first aesthetic clinic groups in the UK to make the polynucleotides treatment widely accessible in multiple locations.

  • Long-term sickness: How worsening mental health is holding back the economy

    May 4, 2024

    Economic inactivity, driven by long-term sickness, is fast becoming one of the most pressing challenges facing the UK economy.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Page 37
  • Next

Trending Articles

  • Government debt repayment ‘could rise to half’ of total taxes

  • Everest Group Announces Dividend

  • Moody’s Corporation Elects Keith Demmings to Board of Directors

  • Lattice to Deliver Keynote at 2026 OCP Global Summit

  • Martin Williams on his favourite Toast the City venues

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook